Monogenic Obesity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-10-24
Clinical Trial Update: DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway [Phase 2]
Phase 2 DAYBREAK trial evaluating setmelanotide in participants with specific gene variants in the MC4R pathway for genetic obesity has comp…